Although our data showed that the miR-125a-5p inhibitor decreased the proportion of Th1 cells and IFN-γ transcript levels in purified CD4+ T cells, no correlation was observed between the levels of miR-125a-5p and the percentage of CD8+IFN-γ+ T cells, which was also increased in the PBMCs from HT patients. This evidence concerns the gene CD8A and hematocrit.